Molecular Insights of Marine Algal Polycyclic Aromatic Compounds as Promising Anti-Viral Agents for Targeting SARS-CoV-2 Proteins – an in Silico Validation

References

• A. Ahmadi, S.Z. Moghadamtousi, S. Abubakar, and K. Zandi, “Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review,” BioMed Research International 2015 (2015): 825203. doi:10.1155/2015/825203
   PubMed Web of Science ®Google Scholar
• L.F. De Almeida, D.S. Falcão, D.M. Lima, D.A. Montenegro, N.S. Lira, P.F. de Athayde-Filho, L.C. Rodrigues, F.V. de Souza, J.M. Barbosa-Filho, and L.M. Batista, “Bioactivities from Marine Algae of the Genus Gracilaria,” International Journal of Molecular Sciences 12, no. 7 (2011): 4550–73. doi:10.3390/ijms12074550
   PubMed Web of Science ®Google Scholar
• R. Thirumalaisamy, P. Murugan,   Srinivasan, S. Arjunan, and T. Selvankumar, “Phytochemical 6-Gingerol –a Promising Drug of Choice for COVID-19,” International Journal of Advanced Science and Engineering 6 (2020): 1482–9.
   Google Scholar
• N. Hasnat, I. Ayesha, R. Thirumalaisamy, K. Suresh, N.I. Muhammad, and B. Zohaib, “Immunomodulatory and anti-Cytokine Therapeutic Potential of Curcumin and Its Derivatives for Treating COVID-19 – a Computational Modeling,” Journal of Biomolecular Structure and Dynamics 4, no. 0 (2022): 5769–84.
   Google Scholar
• R. Thirumalaisamy, M. Bhuvaneswari, K. Suresh, A. Subramanian, T. Selvankumar, R. Yuvarajan, and P. Srinivasan, “Potential COVID-19 Drug from Natural Phenolic Compounds through In Silico Virtual Screening Approach,” Biointerface Research in Applied Chemistry” 11 (2021): 10161–73.
   Web of Science ®Google Scholar
• R. Karthika, R. Thirumalaisamy, P. Velu, A. Subramanian, M. Shanmugam, and N.I. Muhammad, “Molecular Insight of Phytocompounds from Indian Spices and Its Hyaluronic Acid Conjugates to Block SARS-CoV-2 Viral Entry,” Journal of Biomolecular Structure and Dynamics 12 (2022): 1–20. doi:10.1080/07391102.2022.2121757
   Google Scholar
• R.K. Jha, and X. Zi-Rong, “Biomedical Compounds from Marine Organisms,” Marine Drugs 2, no. 3 (2004): 123–46. doi:10.3390/md203123
   Google Scholar
• J. Venkatesan, S. Anil, K. Kim, and M.S. Shim, “Seaweed Polysaccharide-Based Nanoparticles: Preparation and Applications for Drug Delivery,” Polymers 8, no. 2 (2016): 30. doi:10.3390/polym8020030
   PubMed Web of Science ®Google Scholar
• N.P. Patil, V. Le, A.D. Sligar, L. Mei, D. Chavarria, E.Y. Yang, and A.B. Baker, “Algal Polysaccharides as Therapeutic Agents for Atherosclerosis,” Frontiers in Cardiovascular Medicine 5 (2018): 5–53. doi:10.3389/fcvm.2018.00153
   PubMed Web of Science ®Google Scholar
• M.A. Alam, R.S. Parra, M. Bilal, C.A. Afroze, M.N. Ahmed, M.N. Iqbal, and J. Xu, “Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoVID,” Molecules 26, no. 8 (2021): 2134. doi:10.3390/molecules26082134
   PubMed Web of Science ®Google Scholar
• M.F. de Jesus Raposo, R.M.S.C. de Morais, and A.M.M.B. de Morais, “Health Applications of Bioactive Compounds from Marine Microalgae,” Life Sciences 93, no. 15 (2013): 479–86. doi:10.1016/j.lfs.2013.08.002
   PubMed Web of Science ®Google Scholar
• I.C. Dewi, C. Falaise, C. Hellio, N. Bourgougnon, and J.L. Mouget, “Anticancer, Antiviral, Antibacterial, and Antifungal Properties in Microalgae,” in Microalgae in Health and Disease Prevention (Cambridge, MA: Elsevier, 2018), 235–61.
   Google Scholar
• A. Bajpai, S. Davuluri, H. Haridas, G. Kasliwal, H. Deepti,   Sreelakshmi, K.D. Chandrashekar, P. Bora, M. Farouk, and N. Chitturi, “In Search of the Right Literature Search Engine,” Natural Precedings 1 (2011), 1–5.
   Google Scholar
• A. Grewal, H. Kataria, and I. Dhawan, “Literature Search for Research Planning and Identification of Research Problem,” Indian Journal of Anaesthesia 60, no. 9 (2016): 635–9. doi:10.4103/0019-5049.190618
   PubMedGoogle Scholar
• G. Capillo, S. Savoca, R. Costa, M. Sanfilippo, C. Rizzo, A. Lo Giudice, A. Albergamo, R. Rando, G. Bartolomeo, N. Spanò, et al, “New Insights into the Culture Method and Antibacterial Potential of Gracilaria Gracilis,” Marine Drugs 16, no. 12 (2018): 492. doi:10.3390/md16120492
   PubMed Web of Science ®Google Scholar
• S.H. Hoseinifar, S. Yousefi, G. Capillo, H. Paknejad, M. Khalili, A. Tabarraei, H. Van Doan, N. Spanò, and C. Faggio, “Mucosal Immune Parameters, Immune and Antioxidant Defence Related Genes Expression and Growth Performance of Zebrafish (Danio rerio) Fed on Gracilaria Gracilis Powder,” Fish & Shellfish Immunology 83 (2018): 232–7. doi:10.1016/j.fsi.2018.09.046
   PubMed Web of Science ®Google Scholar
• L. Pereira, and A.T. Critchley, “The COVID 19 Novel Coronavirus Pandemic 2020: Seaweeds to the Rescue? Why Does Substantial, Supporting Research about the Antiviral Properties of Seaweed Polysaccharides Seem to Go Unrecognized by the Pharmaceutical Community in These Desperate Times,” Journal of Applied Phycology 32, no. 3 (2020): 1875–7. doi:10.1007/s10811-020-02143-y
   PubMed Web of Science ®Google Scholar
• J.Y. Park, J.H. Kim, J.M. Kwon, H.J. Kwon, H.J. Jeong, Y.M. Kim, D. Kim, W.S. Lee, and Y.B. Ryu, “Dieckol, a SARS-CoV 3CLpro Inhibitor, Isolated from the Edible Brown Algae Ecklonia Cava,” Journal of Bioorganic & Medicinal Chemistry 21, no. 13 (2013): 3730–7. doi:10.1016/j.bmc.2013.04.026
   PubMed Web of Science ®Google Scholar
• X. Chen, W. Han, G. Wang, and X. Zhao, “Application Prospect of Polysaccharides in the Development of anti-Novel Coronavirus Drugs and Vaccines,” International Journal of Biological Macromolecules 164 (2020): 331–43. doi:10.1016/j.ijbiomac.2020.07.106
   PubMed Web of Science ®Google Scholar
• B.R. O’Keefe, B. Giomarelli, D.L. Barnard, S.R. Shenoy, P.K.S. Chan, J.B. McMahon, K.E. Palmer, B.W. Barnett, D.K. Meyerholz, C.L. Wohlford-Lenane, et al, “Broad-Spectrum in Vitro Activity and in Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae,” Journal of Virology 84, no. 5 (2010): 2511–21. doi:10.1128/JVI.02322-09
   PubMed Web of Science ®Google Scholar
• J.K. Millet, K. Séron, R.N. Labitt, A. Danneels, K.E. Palmer, G.R. Whittaker, J. Dubuisson, and S. Belouzard, “Middle East Respiratory Syndrome Coronavirus Infection is Inhibited by Griffithsin,” Antiviral Research 133 (2016): 1–8. doi:10.1016/j.antiviral.2016.07.011
   PubMed Web of Science ®Google Scholar
• Y.C. Wen, K. Hanz, W.C. Ki, S.L. Sze, and L.S. Pau, “Can Algae Contribute to the War with Covid-19?,” Bioengineered 12 (2021): 1226–37.
   PubMed Web of Science ®Google Scholar
• R.M.F. De Jesus, A.M.B. De Morais, and R. M.S.C. De Morais, “Marine Polysaccharides from Algae with Potential Biomedical Applications,” Marine Drugs 13, no. 5 (2015): 2967–3028. doi:10.3390/md13052967
   PubMed Web of Science ®Google Scholar
• T. Silva, P. S. Salomon, L. Hamerski, J. Walter, R. B. Menezes, J.E. Siqueira, A. Santos, J.A.M. Santos, N. Ferme, T. Guimarães, et al, “Inhibitory Effect of Microalgae and Cyanobacteria Extracts on Influenza Virus Replication and Neuraminidase Activity,” PeerJ 6 (2018): e5716. doi:10.7717/peerj.5716
   PubMedGoogle Scholar
• O.A. Khomich, S.N. Kochetkov, B. Bartosch, and A.V. Ivanov, “Redox Biology of Respiratory Viral Infections,” Viruses 10, no. 8 (2018): 392. doi:10.3390/v10080392
   PubMed Web of Science ®Google Scholar
• L. Delgado-Roche, and F. Mesta, “Mesta Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection,” Archives of Medical Research 51, no. 5 (2020): 384–7. doi:10.1016/j.arcmed.2020.04.019
   PubMed Web of Science ®Google Scholar
• R. Cecchini, and A.L. Cecchini, “SARS-CoV-2 Infection Pathogenesis is Related to Oxidative Stress as a Response to Aggression,” Medical Hypotheses 143 (2020): 110102. doi:10.1016/j.mehy.2020.110102
   PubMed Web of Science ®Google Scholar
• S. Derouiche, “Oxidative Stress Associated with SARS-Cov-2 (COVID-19) Increases the Severity of the Lung Disease-a Systematic Review,” Journal of Infecious Disease and Epidemiology 6 (2020): 121.
   Google Scholar
• R. Thirumalaisamy, M. Bhuvaneswari, S. Haritha, S. Jeevarathna, K.S. Sai Janani, and K. Suresh, “Curcumin, Naringenin and Resveratrol from Natural Plant Products Hold Promising Solutions for Modern World Diseases – a Recent Review,” South African Journal of Botany 151 (2022): 567–80. doi:10.1016/j.sajb.2022.06.027
   Web of Science ®Google Scholar
• S. Vasuki, R. Thirumalaisamy, A. Subramanian, and N.I. Muhammad, “Polyphenolic Phytochemicals Exhibit Promising SARS-COV-2 Papain like Protease (PLpro) Inhibition Validated through a Computational Approach, Polycyclic Aromatic Compounds,” Polycyclic Aromatic Compounds 29 (2022): 1–22. doi:10.1080/10406638.2022.2103578
   Google Scholar
• R. Thirumalaisamy, T. Selvankumar, A. Subramanian, and K. Suresh, “Virtual Screening of COVID-19 Drug from Three Indian Traditional Medicinal Plants through in Silico Approach,” Research Journal of Biotechnology 15 (2020): 24–140.
   Web of Science ®Google Scholar
• C. Sansone, C. Brunet, D.M. Noonan, and A. Albini, “Marine Algal Antioxidants as Potential Vectors for Controlling Viral Diseases,” Antioxidants 9, no. 5 (2020): 392. doi:10.3390/antiox9050392
   Web of Science ®Google Scholar
• H.M. Berman, T. Battistuz, T.N. Bhat, W.F. Bluhm, P.E. Bourne, K. Burkhardt, Z. Feng, G.L. Gilliland, L. Iype, S. Jain, et al, “The Protein Data Bank,” Acta Crystallographica Section D Biological Crystallography 58, no. 6 (2002): 899–907. doi:10.1107/S0907444902003451
   PubMedGoogle Scholar
• D. Weininger, “Smiles, a Chemical Language and Information System. Introduction to Methodology and Encoding Rules,” Journal of Chemical Information and Computer Sciences 28, no. 1 (1988): 31–6. doi:10.1021/ci00057a005
   Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7 (2017): 42717–3. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• R. Wu, L. Wang, H.C.D. Kuo, A. Shannar, R. Peter, P.J. Chou, S. Li, R. Hudlikar, X. Liu, Z. Liu, et al, “An Update on Current Therapeutic Drugs Treating COVID-19,” Current Pharmacology Reports 6, no. 3 (2020): 56–70. doi:10.1007/s40495-020-00216-7
   PubMedGoogle Scholar
• A. Allouche, “Software News and Updates Gabedit—a Graphical User Interface for Computational Chemistry Softwares,” Journal of Computational Chemistry 32, no. 1 (2011): 174–82. doi:10.1002/jcc.21600
   PubMed Web of Science ®Google Scholar
• O. Trott, and A.J. Olson, “Auto Dock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading,” Journal of Computational Chemistry 31, no. 2 (2010): 455–61. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• K.J. Bowers, E. Chow, H. Xu, R.O. Dror, M.P. Eastwood, B.A. Gregersen, J.L. Klepeis, I. Kolossvary, M.A. Moraes, F.D. Sacerdoti, et al, “Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters” (paper presented at the Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, SC, November 6, 2006). doi:10.1145/1188455.1188544
   Google Scholar
• R. Thirumalaisamy, A. Subramanian, T. Selvankumar, and S. Gnanendra, “Identification of anti-Diabetic Phytocompounds from Ficus Racemosa and Its Validation through in Silico Molecular Modeling,” International Journal of Advanced Science and Engineering 5, no. 4 (2019): 1085–98.
   Google Scholar
• M.A. Martínez, T.G.M. Hernández, J.B. Correa,  Sarita, and A.M. Camacho-Molina, “Molecular Dynamics Simulations Reveal Structural Differences among Wild-Type NPC1 Protein and Its Mutant Forms,” Journal of Biomolecular Structure and Dynamics 38, (2019): 3527–32.
   PubMed Web of Science ®Google Scholar
• R. Thirumalaisamy, V. Aroulmoji, M.N. Iqbal, M. Deepa, C. Sivasankar, R. Khan, and T. Selvankumar, “Molecular Insights of the Hyaluronic Acid-Hydroxychloroquine Conjugate as a Promising Drug in Targeting SARS-CoV-2 Viral Proteins,” Journal of Molecular Structure 1238 (2021): 130457. doi:10.1016/j.molstruc.2021.130457
   PubMed Web of Science ®Google Scholar
• D. Shivakumar, J. Williams, Y. Wu, W. Damm, J. Shelley, and W. Sherman, “Prediction of Absolute Solvation Free Energies Using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field,” Journal of Chemical Theory and Computation 6, no. 5 (2010): 1509–19. doi:10.1021/ct900587b
   PubMed Web of Science ®Google Scholar
• S.W. Li, C.Y. Wang, Y.J. Jou, S.H. Huang, L.H. Hsiao, L. Wan, Y.J. Lin, S.H. Kung, and C.W. Lin, “SARS Coronavirus Papain-like Protease Inhibits the TLR7 Signaling Pathway by Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6,” International Journal of Molecular Sciences 17, no. 5 (2016): 678. doi:10.3390/ijms17050678
   PubMed Web of Science ®Google Scholar
• L.T. Lin, W.C. Hsu, and C.C. Lin, “Antiviral Natural Products and Herbal Medicines,” Journal of Traditional and Complementary Medicine 4, no. 1 (2014): 24–35. doi:10.4103/2225-4110.124335
   PubMedGoogle Scholar
• B.D. Lindenbach, and C.M. Rice, " “The Ins and Outs of Hepatitis C Virus Entry and Assembly,” Nature Reviews. Microbiology 11, no. 10 (2013): 688–700. doi:10.1038/nrmicro3098
   PubMed Web of Science ®Google Scholar
• G. Muteeb, A. Alshoaibi, M. Aatif, M.T. Rehman, and M.Z. Qayyum, “Screening Marine Algae Metabolites as High-Affinity Inhibitors of SARS-CoV-2 Main Protease (3CLpro): An in Silico Analysis to Identify Novel Drug Candidates to Combat COVID-19 Pandemic.” Journal of Applied Biological Chemistry 63, no. 1 (2020): 79. doi:10.1186/s13765-020-00564-4
   PubMed Web of Science ®Google Scholar
• H.A. Lindner, V. Lytvyn, H. Qi, P. Lachance, E. Ziomek, and R. Ménard, “Selectivity in ISG15 and Ubiquitin Recognition by the SARS Coronavirus Papain-like Protease,” Archives of Biochemistry and Biophysics 466, no. 1 (2007): 8–14. doi:10.1016/j.abb.2007.07.006
   PubMed Web of Science ®Google Scholar
• A. Mazumder, K. Raghavan, J. Weinstein, K.W. Kohn, and Y. Pommier, “Inhibition of Human Immunodeficiency Virus Type-1 Integrase by Curcumin,” Biochemical Pharmacology 49, no. 8 (1995): 1165–70. doi. doi:10.1016/0006-2952(95)98514-A
   PubMed Web of Science ®Google Scholar
• S. Prasad, and B.B. Aggarwal, “Turmeric is the Golden Spice in Herbal Medicine,” in Biomolecular and Clinical Aspects, vol. 2 (Boca Raton, FL: CRCPress/Taylor&Francis, 2011).
   Google Scholar
• K. Ratia, A. Kilianski, Y.M.S. Baez, S.C. Baker, and A. Mesecar, " “Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-like Protease,” Journal of PLoS Pathology 10 (2014): 1004113.
   PubMed Web of Science ®Google Scholar
• E.J. Snijder, E. Decroly, and J. Ziebuhr, “The Nonstructural Proteins Direct Coronavirus RNA Synthesis and Processing,” Journal of Advanced Virus Research 6 (2016): 59–126.
   Google Scholar
• R. Thirumalaisamy, V. Aroulmoji, and N.I. Muhammad, “Molecular Insights of Hyaluronic Acid - Ethambutol and Hyaluronic Acid - Isoniazid Drug Conjugates Act as Promising Novel Drugs for the Treatment of Tuberculosis,” Journal of Biomolecular Structure & Dynamics 16 (2021b): 1–12.
   Google Scholar
• V. Periyannan, R. Thirumalaisamy, K. Suresh, N.I. Muhammad, N. Hasnat, I.A.R. Karthika, and S. Gnanendra, “Whole Genome Analysis and Homology Modeling of SARS-CoV-2 Indian Isolate Reveals Potent FDA Approved Drug Choice for Treating COVID-19,” Journal of Biomolecular Structure and Dynamics 41 (2022): 2772–88.
   PubMed Web of Science ®Google Scholar
• R. Thirumalaisamy, R. Murugan, P. Srinivasan, P. Arjunan, and S. Selvankumar, “Phytochemical 6-Gingerol –a Promising Drug of Choice for COVID-19".International,” Journal of Advanced Science and Engineering 6 (2020): 1482–9. doi. doi:10.29294/IJASE.6.4.2020.1482-1489
   Google Scholar
• C. Wu, Y. Liu, Y. Yang, P. Zhang, W. Zhong, Y. Wang, Q. Wang, Y. Xu, M. Li, X. Li, et al, “Analysis of Therapeutic Targets for SARS-CoV-2 and Discovery of Potential Drugs by Computational Methods,” Acta Pharmaceutica Sinica B 10, no. 5 (2020): 766–88. doi:10.1016/j.apsb.2020.02.008
   PubMed Web of Science ®Google Scholar
• R. Thirumalaisamy, V. Aroulmoji, K. Riaz, C. Sivasankar, and M. Deepa, “Hyaluronic Acid - 2-Deoxy-D-Glucose Conjugate Act as a Promising Targeted Drug Delivery Option for the Treatment of COVID-19,” International Journal of Advanced Science and Engineering (2021): 4–7.
   Google Scholar
• Y.S.M. Aramice, and J.H. Brendan, “Docking and DFT Studies on Ligand Binding to Quercetin 2,3-Dioxygenase,” Journal of Biomolecular Structure & Dynamics 34, no. 11 (2016): 2453–61.
   Google Scholar
• V.D. Menachery, B.L. Yount, K. Debbink, S. Agnihothram, L.E. Gralinski, J.A. Plante, R.L. Graham, T. Scobey, X.Y. Ge, E.F. Donaldson, et al, “A SARS-like Cluster of Circulating Bat Coronaviruses Shows Potential for Human Emergence,” Nature Medicine 21, no. 12 (2015): 1508–13. doi:10.1038/nm.3985
   PubMed Web of Science ®Google Scholar
• Z. Wang, H. Sun, X. Yao, D. Li, L. Xu, Y. Li, S. Tian, and T. Hou, “Comprehensive Evaluation of Ten Docking Programs on a Diverse Set of Protein-Ligand Complexes: The Prediction Accuracy of Sampling Power and Scoring Power,” Physical Chemistry Chemical Physics 18, no. 18 (2016): 12964–75. doi:10.1039/c6cp01555g
   PubMed Web of Science ®Google Scholar
• H. Ben Hlima, A. Farhat, S. Akermi, B. Khemakhem, Y. Ben Halima, P. Michaud, I. Fendri, and S. Abdelkafi, “In Silico Evidence of Antiviral Activity against SARS-CoV-2 Main Protease of Oligosaccharides from Porphyridium sp,” Science of the Total Environment 836 (2022): 155580. doi:10.1016/j.scitotenv.2022.155580
   PubMed Web of Science ®Google Scholar